China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) attributable profit rose to 3.24 billion yuan in the nine months through Sept. 30 from 2.70 billion yuan in the year-ago period.
Revenue at the drug company grew to 19.7 billion yuan from 18.6 billion yuan a year earlier, according to a Friday filing by parent China Resources Pharmaceutical (HKG:3320) with the Hong Kong Exchange.
Shares slid 2% during Monday's trading.
Price (HKD): $46.52, Change: $-0.92, Percent Change: -1.94%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。